Hear experts discuss comprehensive genomic profiling (CGP) via next-generation sequencing (NGS), the standard clinical practice for identifying actionable mutations and genomic signatures to identify cancer patients who may benefit from targeted and immunotherapies, as well as clinical trials.
Learning Objectives
Michelle Shiller is a thought leader in integrating the clinical use of molecular diagnostics, focusing on effective utility, interpretation and application of testing. She has helped to bridge educational gaps in molecular oncology topics such as targeted therapy, prognostics, techniques, genetic disorders and ethical and legal considerations in genomic medicine in order to break down barriers to implementation and adoption.
Watch Webinar
Watch our webinar to learn how Labcorp’s PGDx elio™ plasma focus Dx can accelerate test internalization.